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Summary
OX40 is a T cell costimulator activated by OX40L.
Blockade of the OX40L-OX40 interaction has ameliora-
tiveeffects inanimalmodelsofTcell pathologies. Inor-
der to better understand the interaction between OX40
andOX40L,wehavedetermined thecrystal structureof
murineOX40L and of the humanOX40-OX40L complex
at 1.45 and 2.4 A˚, respectively. These structures show
that OX40L is an unusually small member of the tumor
necrosis factor superfamily (TNFSF). The arrangement
of the OX40L protomers forming the functional trimer
is atypical and differs from that of other members by
a 15 rotation of each protomer with respect to the tri-
mer axis, resulting in an open assembly. Site-directed
changes of the interfacial residues of OX40L suggest
this interface lacksasingle ‘‘hot spot’’ and that instead,
binding energy is dispersed over at least two distinct
areas. These structures demonstrate the structural
plasticity of TNFSF members and their interactions
with receptors.
Introduction
Many members of the tumor necrosis factor superfamily
(TNFSF) and their receptors modulate immune system
activity either by triggering apoptosis or, conversely,
by acting as growth or survival factors (Locksley et al.,
2001). OX40 (also known as TNFRSF4, ACT35, TXGP1L,
or CD134) along with other TNF receptor superfamily
(TNFRSF) members 4-1BB, CD27, CD30, and CD40 are
costimulatory molecules acting at different stages in T
and B cell activation to modulate and control the immune
response (Watts, 2005). The OX40-OX40L pair has been
shown to function relatively late in T cell activation, as
blockade of this pathway reduces memory but not pri-
mary T cell activation. OX40L (also known as TNFSF4,
gp34, and TXGP1) is expressed on the surface of anti-
gen-presenting cells approximately 1–3 days after initial
antigen encounter and interacts with OX40 expressed on
activated T cells (Croft, 2003). This interaction results in
recruitment of TRAF2 (TNF receptor-associated factor
2) and signals for T cell survival in a survivin-dependent
manner (Song et al., 2005). OX40 activity is implicated
in the generation of activated TH1 and TH2 cells as well
as the maintenance of memory T cell populations (Croft,
2003; Weinberg et al., 2004). The cytokine TSLP, which
has been correlatively associated with TH2 pathology
in human asthma and atopic dermatitis, has recently
been shown to trigger OX40L expression on dendritic
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knockout mice are deficient in TH2 responses while
TH1 responses are normal, suggesting that TH2 polari-
zation is the pathway most influenced by OX40 signaling
(Jember et al., 2001; Hoshino et al., 2003). Consistent
with this hypothesis, treatment with anti-OX40L mono-
clonal antibodies which block interaction with OX40
results in reduced cytokine production, antigen-specific
IgE levels, and lung inflammation in murine models of
allergic asthma (Hoshino et al., 2003).
Despite their varied biological roles, TNFSF members
are generally homotrimeric proteins composed of three
jelly-roll protomers. Each protomer is formed by two
b sheets which consist of strands A0AHCF and B0BGDE.
Most TNFSF ligands are type II transmembrane pro-
teins, several of which (e.g., FasL, TNF, BAFF, and
EDA) have processing sites allowing them to be released
from the cell surface to act as soluble factors (Bodmer
et al., 2002). The TNFSF can roughly be divided into
three groups (the conventional, the EF-disulfide-con-
taining, and the divergent) based on sequence and
structural features. The conventional TNFSF members
include TNF, LTa, LTb, Apo2L/TRAIL, TL1A, LIGHT,
FasL, RANKL, and CD40L. This group is very well char-
acterized, as crystal structures are available for five of
them (TNF, LTa, Apo2L/TRAIL, RANKL, and CD40L)
(Bodmer et al., 2002). The other members of the conven-
tional group are easily amenable to homology modeling.
These structures and models indicate that these ligands
all have relatively long loops connecting the CD, DF, and
DE strands, giving the trimers their characteristic pyra-
midal shape. More importantly, the conventional ligands
are all expected to bind receptors in a similar manner in
part because they all have, in the DE loop, a conserved
hydrophobic residue (generally a tyrosine) which has
been shown to be energetically important for receptor
binding in several of the family members.
The second TNFSF ligand group, the EF-disulfide
group, consists of APRIL, BAFF, TWEAK, and EDA. Crys-
tal structures are available for APRIL, BAFF, and EDA
(Hymowitz et al., 2003; Karpusas et al., 2002; Wallweber
et al., 2004). These ligands all possess a disulfide con-
necting the E and F strands and are characterized by
shorter CD and EF loops, resulting in a more globular
shape. Receptor binding by this TNFSF group also dif-
fers from the conventional ligand group, as they lack
the conserved hydrophobic residues in the DE loop. In
addition, three (APRIL, BAFF, and TWEAK) of these
four ligands have been shown to bind very small atypical
TNFRSF members (BR3, TACI, BCMA, and Fn14) (Bod-
mer et al., 2002).
The third, divergent, ligand group contains the re-
maining members of the TNFSF (CD27L, CD30L, GITRL,
4-1BBL, and OX40L). These ligands all have sequences
that are very divergent from each other and from either
the conventional or EF-disulfide groups. No structural
or mutagenesis data are available to validate how these
ligands assemble into trimers or interact with receptors.
OX40L is an example of this group. It is one of the most
divergent members of the TNFSF, with onlyw10%–15%
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very compact, with onlyw132 residues in the entire ex-
tracellular region of human OX40L as compared tow195
residues for the other members of the TNFSF. In addi-
tion to the lack of sequence homology within the TNF
domain, OX40L also has an unusually short linker (7 res-
idues versus an average of 50 for other members of the
TNFSF) between the extracellular TNF homology do-
main and the transmembrane helix with no discernable
proteolytic site, and thus is expected to exist only in
a membrane bound state (Baum et al., 1994; Godfrey
et al., 1994).
In contrast to the globular ligands, TNFRSF members
are elongated molecules composed of an extracellular
domain ofw40 residue pseudorepeats typically contain-
ing six cysteines forming three disulfides. These mod-
ules are termed CRDs (cysteine-rich domains) and can
be further subdivided into smaller submodules based
on the number of cysteines and topology of the cysteine
connectivity (Naismith and Sprang, 1998). A typical CRD
is composed of A1 and B2 tandemly linked subdomains.
The A1 subdomain contains a single disulfide (the 1-2 di-
sulfide), while the B2 subdomain contains two disulfides
which are linked in a 3-5, 4-6 topology. Other subdomain
variants exist, such as the A2, which contains two di-
sulfides, or the B1, which lacks one of the characteris-
tic disulfides. Sequence analysis suggests that, unlike
OX40L, OX40 is a relatively conventional member of the
TNFRSF. The extracellular ligand binding domain of
OX40 is composed of three full CRDs and a partial, fourth
C-terminal CRD (Bodmer et al., 2002). Both CRD1 and
CRD2 have the prototypical A1-B2 linkage, while CRD3
is an atypical CRD with the more unusual A1-B1 linkage.
In order to determine the molecular details of the
OX40-OX40L interaction as well as to better understand
the relationship of OX40L to other members of the
TNFSF, we have determined the structure of the OX40-
OX40L complex. Guided by the structure, we have used
alanine scanning mutagenesis to further dissect the
interaction between OX40 and OX40L.
Results
Structure of OX40L
The structure of mOX40L was solved using multiwave-
length anomalous dispersion (MAD) phasing with NaBr-
soaked crystals (Table 1). This approach was used
after attempts at using molecular replacement to solve
either the mOX40L or receptor complexes failed due
to the low sequence homology and structural similarity
between OX40L and available structures of members
of the TNFSF. The refined 1.45 A˚ mOX40L structure
was then used to solve the structures of the hOX40-
mOX40L and hOX40-hOX40L complexes by molecular
replacement (Table 1). These structures show that the
OX40L protomer is brick shaped and packs together
to form flower-like trimers. These trimers lack the pyra-
midal shape typical of more conventional TNFSF mem-
bers such as Apo2L/TRAIL, TNF, or LT (Figure 1). How-
ever, despite the differences in the appearance and
assembly of the ligand, hOX40 binds at the monomer-
monomer interface as seen in other structures of multi-
domain TNFRSF-ligand complexes (Bodmer et al., 2002)
(Figure 2).Human and murine OX40 ligands (hOX40L and
mOX40L) are less similar to each other than many other
TNFSF orthologs, with only w40% sequence identity,
yet they share the same distinctive features. Both murine
and human OX40L are very compact, making OX40L
more representative of smaller members of the TNFSF
such as GITRL and CD27L. The OX40L TNF homology
domain is followed by a C-terminal extension consisting
of residues 175–183 in hOX40L and residues 178–191 in
mOX40L (Figure 1). In hOX40L, the entire extension is or-
dered and interacts with the BC loop both by backbone
hydrogen bonds as well as via a conserved disulfide
between residues 181 and 97. A second disulfide in
mOX40L connects the AA0 loop to the GH loop and is
not conserved in hOX40L. In both human and murine
OX40L, the strands and loops comprising the jelly-roll
b sandwich monomer sheets (A0AHCF and B0BGDE) are
significantly shorter than in other TNFSF members
such as TNF or Apo2L/TRAIL. In addition to the compact
TNF homology domain, hOX40L has a seven residue
connection to the N-terminal transmembrane domain.
These residues are expected to form a short unstruc-
tured linker and are not visible in the electron density.
The trimeric packing of TNFSF members is generally
very well conserved even among the more distant family
members such as BAFF and EDA. Unexpectedly, the
structures of human and murine OX40L show that the
protomers assemble differently into a trimer than in other
structurally characterized members of the TNFSF (Fig-
ure 1). In OX40L, the monomers are splayed out and
form an angle of w45 with respect to the trimer axis,
which differs from other TNF ligands by w15 rotation
of the monomer. For most TNFSF members, as exempli-
fied by LTa, the angle between the AHCF sheet and the
trimer axis is 25–30. This difference in trimer assembly
correlates with the lack of sequence conservation be-
tween OX40L and other members of the TNFSF (Figure 3)
and accounts for the difficulty in generating high-quality
homology models of the OX40L trimer (S.G.H., unpub-
lished data).
Another unusual aspect of the OX40L trimer is that hu-
man OX40L and murine OX40L have much smaller trimer
interfaces than other structurally characterized TNF li-
gands (Figure 1). The hOX40L trimer interface is particu-
larly compact, with onlyw2,600 A˚2 of accessible surface
area buried upon trimer formation in comparison to
12,000 A˚2 or 5-fold more buried by BAFF and LT (BAFF
and LT, both w12,000 A˚; hOX40L, w2,600 A˚; mOX40L,
w4,000 A˚). An additional striking difference between
the OX40L and other TNFSF members is the absence
in OX40L of the characteristic ‘‘tiles’’ of alternating aro-
matic or hydrophobic residues along the trimer axis first
seen in the structure of TNF (Eck and Sprang, 1989;
Jones et al., 1992). Instead, the trimer interface of murine
and human OX40L is formed by a very short layer of gen-
erally hydrophobic residues from the C strand (L102), F
strand (L138), and the C-terminal tail (Q175). In murine
OX40L, the corresponding residues are I103, T141, and
V175. In addition, L178 from the murine OX40L C-termi-
nal tail also contributes to the trimer interface.
Structure of OX40
In contrast to the distinctive structure of OX40L, OX40 is
a relatively conventional multidomain TNFR (Figure 4). It
Crystal Structure of the OX40-OX40L Complex
1323Table 1. Crystallographic Statistics
Phasing mOX40L
Br Peak Br High Br Inflec Br Low
Space group P63
Unit cell (A˚) a = 75.0 c = 47.6
Wavelength (A˚) 0.9199 0.9050 0.9202 1.5418
Maximum resolution (A˚) 2.0 2.2 2.0 2.6
Completeness (%)a 99.8 (100) 99.8 (100) 99.8 (100) 99.8 (100)
Rsym
a,b 0.065 (0.42) 0.067 (0.45) 0.047 (0.33) 0.045 (0.20)
Reflections measuredc 91,256 68,648 91,337 42,450
Reflections uniquec 10,438 7,858 10,452 4,990
Resolution for phasing 2.8 2.8 2.8 2.8
Phasing power iso 0.0 1.7 0.97 1.7
Phasing power anom 1.13 1.3 0.23 0.62
FOM acentric, centric 0.66, 0.62
mOX40L mOX40L-hOX40 hOX40L-hOX40
Data Collection
Space group P63 R32 R32
Resolution (A˚)a 30–1.45 (1.50–1.45) 30–2.0 (2.07–2.00) 30–2.4 (2.49–2.40)
Unit cell constants (A˚) a = 74.5 c = 49.0 a = 104.7 c = 478.2 a = 111.9 c = 233.2
Rsym
a,b 0.068 (0.466) 0.069 (0.272) 0.055 (0.505)
No. observations 388,637 312,989 135,176
Unique reflections 27,220 68,124 22,255
Completeness (%)a 100 (100) 98.6 (96.4) 99.8 (100)
Asymmetric unit 1 ligand protomer 2 ligand:receptor protomers 1 ligand:receptor protomer
Refinement
Resolution (A˚) 30–1.45 30–2.0 30–2.4
Final R,d Rfree (%) 16.5, 19.2 22.1, 24.7 20.8, 25.1
No. solvent atoms 108 181 87
Rmsd bonds, angles (A˚, ) 0.007, 1.3 0.007, 1.0 0.007, 1.1
Ramachandran plot (%)e 90.4; 8.7; 0.9; 0 92.1; 7.1; 0.9; 0 90.4; 8.7; 0.9; 0
a Numbers in parentheses refer to the highest resolution shell.
b Rsym = S jI 2 <I>j/S I. <I> is the average intensity of symmetry-related observations of a unique reflection.
c Bijvoet reflections are kept separate in the Br statistics.
d R = S jFo 2 Fcj/SFo.
e Percentage of residues in the most favored, additionally allowed, generously allowed, and disallowed regions of a Ramachandran plot.is composed of three full CRDs and a partial C-termi-
nal CRD which form a contiguous structure. Superposi-
tion of the three independent copies of hOX40 (two in
the mOX40L-hOX40 asymmetric unit and one in the
hOX40L-OX40 asymmetric unit) reveals that CRD1 and
CRD2 form a rigid unit while there is some rotational free-
dom between the subdomains of CRD3 and the partial
CRD4. The first and second CRDs have the same di-
sulfide connectivity as the corresponding domains of
TNFR1 and in the terminology of Naismith and Sprang
(1998) are composed of A1, B2 modules. As in other
TNFRs such as DR5, CRD2 is the best conserved struc-
turally, with only a one residue deletion with respect to
TNFR1 and an rmsd of 0.9 A˚2 on all equivalent C-a
when superimposed on TNFR1 CRD2 (residues 55–97).
CRD3 in hOX40 differs more than CRD1 and CRD2
from its counterpart in TNFR1 or DR5, as it is smaller
and lacks one of the canonical disulfides (Figures 4
and 5). CRD3 contains an A1, B1 module rather than
the A1, B2 architecture of CRD1 and CRD2. To our
knowledge, this structure of hOX40 CRD3 contains the
first experimentally determined B1 subdomain. As dis-
cussed above, B1 modules are defined in part by their
lack of a conserved disulfide (Naismith and Sprang,
1998). In the case of OX40, the disulfide formed by the
fourth and sixth cysteines in CRD3 (the 4-6 disulfide) is
missing. This missing disulfide in hOX40 CRD3 is notreplaced by either hydrogen bonds or hydrophobic in-
teractions but rather the entire module is smaller due
to shortening and rearrangement of intervening loops.
This rearrangement causes the backbone of the remain-
ing 3-5 disulfide to be in an antiparallel orientation rather
than the parallel orientation seen in B2 modules. A long
disulfide-containing loop follows the B1 module. The
connectivity and structure of this loop are compatible
with it being an A1 module of a vestigial CRD4.
B1 modules have been detected in the sequences of
a number of other TNFRSF members including OPG,
RANK, TNFR2, LTbR, HVEM, DcR3, CD30, 4-1BB,
GITR, EDAR, and RELT. Examining the sequences of
these B1 modules along with the structure of the OX40
B1 modules indicates that the B1 modules form two dis-
tinct groups based on their size and on which disulfide
pair is lacking: a smaller group consisting of OX40-like
B1 modules which lack the 4-6 disulfide and a larger
group of B-1 modules that are more B2-like and lack
the 3-5 disulfide (Figure 5). Like OX40, GITR, EDAR
(CRD3), and possibly RANK (CRD3) all possess the
smaller B1 module lacking the 4-6 disulfide. The second,
more B2-like group is defined by having similar se-
quence and cysteine spacing as B2 modules. In this
group, the 3-5 disulfide is replaced by an aromatic/small
amino acid pair, most frequently histidine and glycine.
Receptors EDAR (CRD2), CD40, DR6, DcR3, LTbR,
Structure
1324Figure 1. The OX40L Trimer Differs from
Other TNFSF Members
(A) The hOX40L trimer is rendered as ribbons.
The individual monomers are colored pink,
green, and blue. The residues along the trimer
axis are shown as sticks.
(B) Ribbon rendering of the LT trimer (PDB ID
code 1TNR) colored and labeled similarly to
(A). Note the close packing of the protomers
along the trimer axis.
(C) The LT protomer (gray) is superimposed
on one of the hOX40L protomers, showing
that hOX40L has shorter strands but that
the protomer’s structure is conserved. Ap-
proximate hOX40L trimer axis is shown as
a red arrow. The angle between the trimer
axis and the protomers was calculated by
taking the dot product between the vector
defining the trimer axis and vectors defined
by the C-a atoms in the C and F strands.
(D) The LT trimer (gray) superimposed on
hOX40L, showing that the trimer assemblies
differ. Black arrow, approximate LT trimer
axis; red arrow, hOX40L trimer axis.
(E and F) Slice through hOX40L (E) and LT (F),
showing that hOX40L has a much smaller
trimer interface.TNFR2, and RANK (CRD2) are all predicted to possess
one or more of these larger, more B2-like modules.
The OX40-OX40L Complex
Three copies of OX40 bind to the trimeric ligand to form
the OX40-OX40L complex. Each copy of OX40 binds at
a monomer-monomer interface on OX40L, forming an
extensive interface (2132 A˚2 hOX40-hOX40L; 2605 A˚2
hOX40-mOX40L) (Figures 2 and 6). This interface is larger
than that seen in either the TNFR1-LT (Banner et al.,
1993) or DR5-Apo2L/TRAIL (Hymowitz et al., 1999; Mon-
gkolsapaya et al., 1999) complexes and is split equally
between each monomer (473 A˚2 for the F180-containing
‘‘right’’ monomer; 640 A˚2 for the N166-containing ‘‘left’’
monomer). Unexpectedly, OX40 uses residues from
CRD1 (355 A˚2), CRD2 (497 A˚2), and CRD3 (167 A˚2) to
bind OX40L. In contrast, in the structures of TNFR1-LT
and DR5-Apo2L, only residues from CRD2 and CRD3
are used, with both CRDs making approximately equal
contributions in binding ligand. OX40 uses the same
general portions of CRD2 (the A1 loop and immediatelyfollowing residues) and CRD3 (primarily the A1 loop) as
used by TNFR1 or DR5 but makes additional contacts
using CRD1. The ligand portion of this interface is even
more discontinuous. Thirty-one hOX40L residues from
11 different secondary structure elements including the
unusual C-terminal tail contact the receptor.
Overall, the OX40L-OX40 complex structure spans
w80 A˚ (Figure 2). This distance, in conjunction with an
w40 amino acid linker between the vestigial CRD4
and the OX40 transmembrane domain, suggests that
the complex could connect cells whose surfaces are
w100–150 A˚ apart. This distance is compatible with
the dimensions of other ligand-receptor complexes
which extend between antigen-presenting cells and T
cells such as the MHC-TCR complex and the B7-CD28
costimulatory complex (Schwartz et al., 2002).
Comparison of the free mOX40L structure and the
mOX40L-hOX40 complex indicates that there are no
significant alterations in ligand conformation that are
attributable to receptor binding. Two loops (the AA0 loop
and residues 79–85 in the A0B0 loop) are significantly
Crystal Structure of the OX40-OX40L Complex
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however, both of these loops in the free structure are in-
volved in crystal packing contacts, which likely drives
the alterations in conformation.
Comparison of the human and murine complex struc-
tures helps explain why, despite their lack of high se-
quence similarity, both mOX40L and hOX40L bind
hOX40 (Figure 6). In general, the murine and human
OX40L surfaces are very distinct; of the 44 residues
which bury any surface area in the mOX40L-hOX40 com-
plex, only 26 are also involved in the hOX40L-OX40 inter-
face. Of those 26 shared residues, only 11 are identical
between mOX40L and hOX40L. The identical residues
account for onlyw360 A2 of the ligand interface (the to-
tal ligand buried surface area is w1100 A2). Six of the
unshared residues are located in the C-terminal tail of
mOX40L, which is significantly longer in mOX40L than
in hOX40L. Nonetheless, two critically important resi-
dues, F180 and N166, are conserved between human
and murine OX40L and make similar contributions to
binding receptor. Mutational analysis has identified
both residues as being crucial for receptor affinity (see
below).
Functional Characterization of the
OX40L-OX40 Complex
In order to determine which portions of the hOX40L sur-
face contribute to receptor affinity, ten residues (Q65,
Figure 2. The hOX40-OX40L Complex
hOX40L is shown as a molecular surface in the same orientation as
Figure 1. The three protomers forming the trimer are colored pink,
blue, and green, respectively. One copy of hOX40 is shown as
a tube with CRD1, CRD2, CRD3, and the vestigial CRD4 colored yel-
low, orange, red, and purple, respectively. Disulfide bonds in OX40
are rendered as sticks, with the sulfur atoms shown as spheres.
The N and C termini of the receptor are labeled. The other two copies
of OX40 are shown with transparent molecular surfaces. There are
seven residues missing from the N terminus of the ligand which
form a linker connecting to the transmembrane domain. These res-
idues are disordered in the electron density and are likely flexible.
The complex is oriented such that the membranes of the ligand-
and receptor-containing cells would be at the top and bottom of
the figure, respectively.Q80, E123, T144, K146, D147, D162, H164, N166, and
F180) distributed over the surface were chosen for mu-
tation to alanine in the context of the N90D, N114D dou-
ble glycosylation mutant. Of these residues, four (Q65,
K146, D147, and H164) resulted in severely diminished
expression, likely due to folding or secretion defects.
The remaining six mutant proteins were shown by size-
exclusion chromatography to be properly assembled
trimers. The IC50 of these six mutants to compete for
hOX40 was assessed in a competition ELISA assay
(Table 2; Figure 6B). Two of these substitutions, F180A
in the C-terminal extension and N166A in the H strand,
both resulted in undetectable binding for hOX40.
Substitutions at Q80 (AA0 loop) and D162 (GH loop)
had more moderate effects, while the affinity of proteins
with mutations at T144 (F strand) and E123 (DE loop)
were essentially unchanged. The four residues which
do affect ligand affinity for receptor do not form a com-
pact region but instead are dispersed over the hOX40-
hOX40L interface. The two crucial residues F180 and
N166 are diagonally at opposite ends of the monomer-
monomer interface. F180 interacts with a hydrophobic
region on hOX40 CRD1, while N166 forms hydrogen
bonds to the backbone of hOX40 residues W86 and
C87 at the juncture of CRD2 and 3. F180 and N166
are conserved in murine OX40L (Y182 and N169) and
make similar interactions in the hOX40-mOX40L com-
plex. Q80, like F180, interacts with CRD1 but forms hy-
drogen bonds to the backbone of V53 rather than mak-
ing hydrophobic contacts. D162 makes van der Waals
contacts near to where N166 binds. The murine equi-
valents of Q80 and D162 (N82 and H165) do not make
similar interactions.
Figure 3. Structure-Based Sequence Alignment of the TNF Homol-
ogy Domain of Representatives from TNFSF Subfamilies
Structure-based sequence alignment of the TNF homology domain
of representatives from the divergent (OX40L), conventional (LT,
11% sequence identity with hOX40L), and EF-disulfide (BAFF,
10% sequence identity with hOX40L) TNFSF subfamilies. Residues
forming b strands are underlined. OX40L strands are also shown
as green arrows above the sequences and are labeled. Residues
which bury at least 50% of accessible surface area upon binding re-
ceptor are highlighted in red. Cysteine residues are colored yellow.
OX40L residues which resulted in at least a 10-fold, >3-fold, or no
decrease in IC50 are colored white, orange, or green, respectively.
In the LT sequence, the hydrophobic residue (Y108) in the DE loop
which is conserved in the ‘‘conventional’’ TNFSF group is colored
white (Banner et al., 1993; Hymowitz et al., 1999).
Structure
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ergy in the hOX40-hOX40L interface is not concentrated
in one location but is spread out to at least two areas,
similar to what was seen for Apo2L/TRAIL interacting
with DR5. However, the OX40-OX40L complex differs
from the complexes formed by conventional TNFSF
members with regard to the distribution of binding en-
ergy and the role of the ligand DE loop. In OX40L, unlike
in the Apo2L/TRAIL- or LT-receptor complexes, there is
no significant hydrophobic contact between the DE loop
and the A1 loop of CRD2. The one residue within the li-
gand DE loop which does extensively contact receptor,
E123, does not contribute energetically to binding.
Figure 4. Structure of OX40 B1 Module
(A) Superposition of the three copies of hOX40, showing its overall
structure as well as variation in the relative position of CRD3 and
CRD4. The sulfur atoms of the disulfide bridges are shown as
spheres. The two copies of hOX40 from the hOX40-mOX40L com-
plex are colored yellow and red, and the copy from the hOX40-
hOX40L complex is colored orange. CRD locations are indicated
and CRD3 is boxed.
(B) Superposition of TNFR1 (in gray) taken from the LT complex
(PDB ID code 1TNR; Banner et al., 1993) with DR5 (in orange). The
sulfur atoms of the disulfide bonds in TNFR1 and DR5 are shown
as yellow and orange spheres, respectively.
(C) Close-up of OX40 CRD3 showing the A1 and B1 subdomains and
their disulfide connectivity. CRD3 is colored and in gradations from
blue (N-terminal) to red (C-terminal). Disulfides are rendered as
sticks. The direction of the 3-5 disulfide backbone is indicated by
arrows.
(D) Close-up of TNFR1 CRD3 (residues 97–138, PDB ID code 1TNR)
colored and labeled similarly to (B). The direction of the backbone of
the 3-5 disulfide in the TNFR1 B2 module is antiparallel rather than
the parallel orientation seen in the OX40 B1 module.Discussion
Both the structural and mutagenesis data show that the
OX40-OX40L interface is not a contiguous patch with
a single ‘‘hot spot’’ but instead is distributed over the sur-
face of hOX40L in at least two general areas. Mutagene-
sis data indicate that residues on both sides of the mono-
mer-monomer interface are important for high-affinity
binding, and, further, that contacts made by three
hOX40 CRDs contribute to the binding affinity. The im-
portance of F180, which is located in the hOX40L C-ter-
minal tail, indicates that this feature, which is also pres-
ent in murine and cyno OX40L sequences, is not just
a structural oddity but that it has an important role in
hOX40L function (Figure 6B). Despite the extensive inter-
face between hOX40 and hOX40L, the affinity of mono-
meric hOX40 for hOX40L was found to be w150 nM
(Table 2), which is in good agreement with values re-
ported in the literature measured using other techniques
(Al-Shamkhani et al., 1997) but is somewhat lower than
had been reported for other multidomain TNFR-ligand
interactions. However, because in vivo OX40L is ex-
pected to be membrane bound, other phenomena such
as local clustering may lead to increased apparent
affinity.
Two unusual features distinguish the OX40-OX40L
complex from other TNFSF-TNFRSF complexes: the un-
usual ‘‘open’’ OX40L trimer interface and the extensive
contacts made by OX40 CRD1 to OX40L (Figures 1 and
6). These features expand the TNFSF-TNFRSF repertoire
of interactions. Until now, TNFSF ligand-multi-CRD
Figure 5. Sequence Alignment of CRDs Containing B1 Modules
(A) Sequence alignments of B1 modules lacking the 4-6 disulfide. The
A and B modules are labeled. TNFR1 CRD3 is included as a reference
of a conventional A1, B2 containing a CRD which has been structur-
ally characterized. Cysteine residues are highlighted in yellow. Cys-
teine connectivity is indicated by lines above the sequences.
(B) Sequence alignment of CRDs containing B1 modules lacking the
3-5 disulfide (the ‘‘B2-like’’ B1 modules). Sequences of TNFR1
CRD2, DR5 CRD2, and OX40 CRD2 are included as examples of
conventional A1, B2 containing CRDs which have been structurally
characterized. The aromatic/small residue pair replacing the 3-5
disulfide in the B2-like B1 modules is highlighted in blue.
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1327Figure 6. Open Book View of the hOX40L-
hOX40 Interface
(A) hOX40L and one receptor are rendered as
molecular surfaces. Residues in the interface
are colored by percentage of accessible sur-
face area buried upon complex formation
(1%–25%, light yellow; 25%–50%, yellow;
50%–75%, orange; 75%–100%, red). Poten-
tial glycosylation sites are colored magenta.
Ligand residues N90 and N114 were mutated
to Asp to remove potential glycosylation
sites. Extra density indicative of glycosylation
was observed at ligand residue 152 and re-
ceptor residue 160. Residues of interest are
labeled. Underlined residues are identical in
murine and human OX40L.
(B) hOX40L is rendered as in (A) but with res-
idues with a greater than 10-fold increase or
5-fold increase in IC50 when mutated to ala-
nine colored red and orange, respectively.
Residues which had less than a 5-fold change
in IC50 when mutated to alanine are colored
green.receptor interactions have all been interpreted using the
rubric of the DR5-Apo2L/TRAIL and TNFR1-LT interac-
tions which implied that only CRD2 and CRD3 were likely
to contact ligand. In light of the OX40 complex structures
reported here, it is possible that CRD1 plays a more im-
portant role in other TNFSF interactions than previously
thought. For example, some disease-causing mutations
in ectodysplasin (EDA) map to surface residues away
from the areas where CRD2 and CRD3 from either
EDAR or XEDAR are expected to bind (Schneider et al.,
2001; Hymowitz et al., 2003). Interestingly, these
changes (A356D, R357P in the EDA BC loop and
D298H, G299S in the EDA FG loop) map to areas of the
EDA surface analogous to where OX40L contacts OX40
CRD1, indicating that EDAR and XEDAR (the receptors
for the EDA-A1 and EDA-A2 splice variants, respectively)
may also use CRD1 to contact ligand.
The structures of the OX40 complexes may shed new
light on findings involving other OX40 interactions. For
instance, feline immunodeficiency virus, FIV, has re-
cently been shown to require feline OX40 as a coreceptor
for entry into T cells (de Parseval et al., 2004; Shimojima
et al., 2004). Elder and coworkers have mapped the res-
idues crucial for FIV interactions with feline OX40 to the
tip of CRD1. Alteration of five residues in hOX40 CRD1
(H44S, R58G, S59D, N61D, and V63K) is sufficient to con-
fer FIV binding equivalent to that of feline OX40 (de Par-
seval et al., 2005). These residues are distal from the
receptor cell membrane and are not involved in bindingOX40L, consistent with biochemical data that soluble fe-
line OX40L does not compete with FIV for binding feline
OX40. However, the ability of feline OX40L to affect bind-
ing of FIV to feline OX40 may be different in vivo, where
OX40L is membrane bound rather than soluble. The
hOX40-hOX40L complex shows that the residues in
OX40 CRD1 involved in binding FIV are likely to be very
close to the ligand cell membrane (Figures 2 and 7).
The presence of the ligand cell membrane may sterically
hinder FIV binding to OX40 in vivo.
Table 2. Effect of Alanine Mutations on hOX40L-hOX40
Interactions in a Competition ELISA
Protein IC50 (nM)
Fold Change in IC50
(Mutant/N90D, N114D)
WT 139 6 43 2.2
N90D, N114D 62 6 2 1.0
F180A ND ND
N166A ND ND
Q80A 537 6 111 8.6
D162A 425 6 73 6.9
T144A 139 6 14 2.2
E123A 186 6 5 3.0
IC50s are the average of three independent measurements. All mu-
tations are in the N90D, N114D background. Fold change values are
relative to the IC50 of hOX40L containing the double mutation
(N90D, N114D). Only values >3-fold different from the reference
are considered significant. ND, no detectable competition.
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unusual not only within the TNFSF but also even when
compared to the distantly related C1q family, which con-
sists of homo- and heterotrimeric complexes of TNF-like
protomers. Structures of several C1q family members
are available including C1q (Gaboriaud et al., 2003),
acrp-30 (Shapiro and Scherer, 1998), and the NC1
domains from collagens X (Bogin et al., 2002) and VII
(Kvansakul et al., 2003). All of these proteins form closed
trimers with aromatic tiles along the trimer axis. The
even more remotely related bacteriophage PRD1 spike
protein still forms a closed trimer despite other struc-
tural differences (Merckel et al., 2005). The lack of these
features in OX40L differentiates it from even these very
distant homologs.
In summary, the structure of the OX40-OX40L com-
plex shows that the ligand itself as well as the complex
are more divergent than had been expected from se-
quence analysis. The OX40L trimer differs from that of
other known TNFSF members as well as from distant
homologs in its assembly, while OX40 makes more ex-
tensive contacts including novel interactions mediated
by CRD1 and the OX40L C-terminal tail that have not
been seen in other TNFRSF members. In addition to re-
vealing the limitations of homology modeling in predict-
ing variations in quaternary structures, these structures
provide a wider insight into the possibilities available to
the TNFSF and their receptors.
Experimental Procedures
Protein Expression
DNA encoding residues 51–198, 51–183, and 29–170 of murine
OX40L (mOX40L), human OX40L (hOX40L), and human OX40
(hOX40), respectively, were cloned into a pET 15b expression vector
by PCR and then subcloned into the baculovirus transfer vector
pAcGP67-B and used for transfection and subsequent viral amplifi-
cation. To decrease heterogeneity of hOX40L due to glycosylation,
Figure 7. FIV Binding Site Is Located on the Tip of hOX40 CRD1
hOX40 CRD1 is shown as a gray tube. Disulfides are rendered as
sticks with the sulfur atoms colored yellow. Residues which bury
at least 50% of their accessible surface area in the ligand interface
are shown as sticks and colored orange. The five residues which
confer the ability to bind FIV when mutated to their feline OX40 coun-
terparts are shown as blue sticks. The residues are on the opposite
side of CRD1 from the residues involved in binding ligand.residues 90 and 114 were mutated to aspartic acid by site-directed
mutagenesis (QuickChange mutagenesis kit, Stratagene). Asn to
Asp substitutions at positions 152 and 157 severely decreased ex-
pression levels and were therefore not pursued. The resulting viral
stocks were used for protein expression in Hi5 cells. Following
growth at 27C for 3 days, cell culture media were harvested by cen-
trifugation, treated with nickel chloride, calcium chloride, and Tris
buffer (pH 8.0), then filtered prior to passage over an Ni-NTA column
to isolate recombinant proteins. His tags were removed by thrombin
cleavage overnight and the proteins were subsequently further puri-
fied by size exclusion chromatography on an S-75 or S-200 column
prior to concentration. Complexes of mOX40L-hOX40 and hOX40L-
hOX40 were further purified by size exclusion chromatography. Final
buffer conditions were 100 mM NaCl, 20 mM Tris (pH 8.0) for mOX40,
and 100 mM NaCl, 20 mM Tris (pH 8.2) for mOX40-OX40 and hOX40-
OX40. All protein sequences were verified by mass spectrometry
and N-terminal sequencing.
Crystallization and Data Collection
Crystals of mOX40L grew by vapor diffusion after approximately 2
weeks in sitting drops containing 1 ml protein and 1 ml well solution
consisting of 0.1 M sodium acetate (pH 4.5), 2.0 M ammonium sul-
fate at 19C. Crystals of mOX40L-OX40 and hOX40L-OX40 were
grown by the same procedure but with well solutions of 0.1 M
NaCl, 0.1 M bis-Tris (pH 6.5), 1.4 M ammonium sulfate and 8%
PEG 20,000, 0.1 M MES (pH 6.5), respectively. Prior to data collec-
tions, mOX40L, mOX40L-OX40, and hOX40L-OX40 were immersed
in artificial mother liquor consisting of the well solution with water re-
placed by either 20% glycerol (mOX40L) or 20%–25% ethylene gly-
col (mOX40L-hOX40 and hOX40L-hOX40). For phasing, mOX40L
crystals were soaked for 60 s in cryoprotectant solution supple-
mented with 1.2 M NaBr prior to flash-cooling in liquid nitrogen. A
four-wavelength Br MAD experiment was collected at beamline
5.0.2 at Advanced Light Source (ALS). Subsequently, a 1.45 A˚ native
data set was collected at beamline F1 at Cornell High Energy Syn-
chrotron Source (CHESS). Two bromine sites were located and
phase refinement was performed using the program SHARP. Native
data sets for mOX40L-OX40 and hOX40L-OX40 were collected at
beamline 14-2 by MXpress at European Synchrotron Radiation Fa-
cility (ESRF) and at ALS beamline 5.0.2, respectively. All data sets
were processed using the HKL package (Otwinowski and Minor,
1997). The structures of mOX40L-OX40 and hOX40L-OX40 were
solved by molecular replacement with the program AMoRe (Navaza,
2001) using the refined mOX40L and mOX40L-OX40 structures,
respectively, as search models. Refinement of all structures was
done using the program REFMAC (Winn et al., 2003). See Table 1
for crystallographic statistics.
Alanine Scanning Mutagenesis
Single alanine mutations were made in the background of the
hOX40L double glycosylation mutant at residues Q65, Q80, E123,
T144, K146, D147, D162, H164, N166, and F180 using the Quick-
Change Site-Directed Mutagenesis Kit (Stratagene). Mutations at
Q65, K146, D147, and H164 resulted in significantly decreased ex-
pression levels and were not purified or characterized. The remain-
ing six alanine mutants were expressed and purified from insect
cells as described above. Mutations were verified by DNA sequenc-
ing and mass spectrometry. Final buffer conditions were 150 mM
NaCl, 20 mM Tris (pH 8.0).
Competition ELISA Binding Experiments
hOX40 was dialyzed into PBS and biotinylated using a 4-fold molar
excess of biotin-NHS-LC. Serial dilutions of biotinylated hOX40 were
then tested for binding to a plate coated with mOX40L. The dilution
which gave approximately 50% saturating signal was used in the so-
lution binding assay in which the biotinylated hOX40 was incubated
with increasing concentrations of each hOX40L alanine mutant for 1
hr. The solutions were then transferred to mOX40L-coated plates for
15 min to capture unbound receptor. Biotinylated hOX40 was de-
tected with tetramethyl benzidine substrate and the absorbance at
450 nM was measured. IC50 was calculated as the concentration
of hOX40L alanine mutant in the solution binding stage that inhibited
50% of the receptor from binding to immobilized mOX40L.
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